Navigation Links
WED/RLS Foundation Sheds Light On TranquilMed's Drug-free Solution
Date:7/18/2013

PROVO, Utah, July 18, 2013 /PRNewswire/ -- TranquilMed, improving quality of life for RLS sufferers through light therapy, announced that the WED Foundation (formerly the RLS Foundation) provided a favorable review on their model 120 RL, in their newly improved newsletter, Nightwalkers. The results showed the model 120 RL to be as effective as prescription drugs, without the harmful side effects.

(Logo: http://photos.prnewswire.com/prnh/20130718/LA49096LOGO)

According to the WED Foundation, "This new NightWalkers feature was developed after many requests from our members to provide information on non-medication treatment options to relieve Willis-Ekbom disease (restless legs syndrome) symptoms. Our chief criterion for product selection is that the product/device has been reviewed by the Food and Drug Administration in the U.S., or a similar agency in another country, and has been deemed safe."

Ten individuals with mild, moderate or severe WED/RLS symptoms tested this medical-grade light therapy system for an average of eight weeks. Six participants reported a lessening of WED/RLS symptoms and would recommend the product to others.  This efficacy rate of 60% is comparable to the efficacy rates of the predominant prescription drugs used to treat WED/RLS today. 

"As an RLS sufferer, I've been using light therapy for almost 3 years," said Rich Hoopes, CEO of TranquilMed.  "Personally, I am so grateful to have an option as effective as drugs but without the side effects.  Our goal is to share it with as many people as possible to help them improve their quality of life."

For more information on the review, visit:  http://restlesslegtreatment.ca/wed-rls-foundation-product-review-of-120-rl/

About TranquilMed

TranquilMed improves the quality of life for RLS sufferers through light therapy.  RLS sufferers who are frustrated with drugs can treat themselves as effectively with light therapy, without fear of the side-effects.  For more information visit http://restlesslegtreatment.ca/

PR Contacts:

Rich Hoopes
Email: rich.hoopes@tranquilmed.com
Phone: 888-775-2256


'/>"/>
SOURCE TranquilMed
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
3. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
4. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
5. National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law
6. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
7. Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance
8. The Galien Foundation Announces New "Best Medical Technology" Award Category for 2012 Prix Galien USA Awards Program
9. Brain Research Foundation Announces Grant To Study Concussive Events Among Grade School Children
10. Elsevier and Russias Skolkovo Foundation Sign Access Agreement to SciVerse Scopus and SciVal Funding
11. AUA Foundation Launches Campaign to Address Stigma of Overactive Bladder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
Breaking Medicine News(10 mins):